17.03.2023 • News
Sandoz Builds Biologics Plant in Slovenia
Sandoz, the generics and biosimilars arm of Swiss drugmaker Novartis, has signed a Memorandum of Understanding to build a biologics production plant in Lendava, Slovenia.
News
17.03.2023 • News
Lummus Wins Kazakhstan Butadiene Contracts
Lummus Technology has received a contract to supply multiple technologies to Butadiene LLP for a new petrochemical complex in Atyrau, Kazakhstan.
17.03.2023 • News
EU Commission Opens Basket of “Green” Plans
Ahead of a summit of EU leaders on Mar. 23-24, the European Commission has shaken out a cornucopia of proposals to stimulate green investment in the 27-member bloc.
16.03.2023 • News
Novo Nordisk to Cut US Insulin prices from 2024
Danish drugmaker Novo Nordisk has added its name to the list of insulin producers cutting prices for US retail buyers, following up on Eli Lilly’s announcement of price cuts and in response to growing pressure from the White House.
16.03.2023 • News
Bayer to Spend $1 Billion on US Drug R&D
Bayer is looking to spend $1 billion on drug research and development in the United States during 2023 as part of a plan to double its sales in the country by the end of the decade.
16.03.2023 • News
Apollo Takes Univar for $8.1 Billion
Private equity group Apollo has agreed to acquire Univar Solutions for $8.1 billion. The transaction also includes a “minority” investment from a wholly owned subsidiary of the Abu Dhabi Investment Authority.
Supply Chain Due Diligence Act
On Jan. 1, 2023, the Supply Chain Due Diligence Act (“LkSG”) came into force in Germany.
Centrally Controlled Logistics for Covid-19 Vaccines
Examples of national logistics solutions in the UK, the Netherlands and Belgium show how high availability and low costs can be brought down to a common denominator.
15.03.2023 • News
Pfizer Takes Seagen for $43 Billion
Pfizer has agreed to acquire Seagen, a global biotech focused on developing cancer treatments, for $43 billion. The announcement comes just a couple of weeks after the Wall Street Journal reported that the two companies were in talks.
15.03.2023 • News
Sanofi Buying Diabetes Specialist Provention Bio
Paris-based French drugmaker Sanofi has agreed to acquire Provention Bio for $25 per share in cash, representing an equity value of about $2.9 billion. The publicly traded US biopharma focuses on intercepting and preventing immune-mediated diseases including type 1 diabetes (T1D).
15.03.2023 • News
Sumitovant Closes Myovant Purchase
US biopharma Sumitovant – a wholly owned subsidiary of Japan’s Sumitomo Pharma – has closed its purchase of the remaining equity in Myovant Sciences, taking full control of the Swiss clinical-stage biopharma for about $1.7 billion. Myovant will now be delisted from the New York Stock Exchange.
14.03.2023 • News
Lilly Insulin Price Cut Revives US Discussion
As the discussion surrounding the high price of insulin in the US continues unabated, drugmaker Eli Lilly implemented price reductions of 70% for its most commonly prescribed insulin products at the beginning of March.
14.03.2023 • News
LyondellBasell to Acquire Mepol Group
LyondellBasell has entered into a definitive agreement to acquire Mepol Group, a manufacturer of recycled, high-performing engineering compounds based in Italy and Poland.
14.03.2023 • News
Coolbrook and Linde Collaborate on Cracker Electrification
Finnish technology and engineering company Coolbrook has signed a partnership agreement with Germany’s Linde Engineering to develop and deploy its RotoDynamic Reactor (RDR) technology that replaces fossil fuels with clean electricity for heating the furnaces in ethylene crackers.
13.03.2023 • News
Ineos and Wintershall Dea in “CCS First”
In the presence of Danish royalty, Ineos and Wintershall Dea, lead players in 23-member Project Greensand consortium, last week inaugurated what is being touted as the world’s first safe injection of carbon dioxide – into a depleted North Sea oil field operated by Ineos.
13.03.2023 • News
Adaptimmune and TCR2 Agree Merger
Clinical stage biotechs Adaptimmune and TCR2 Therapeutics have agreed to merge, forming what they said would be a “preeminent cell therapy company focused on creating solid tumors” with projected sales of about $27 billion by 2026.
13.03.2023 • News
Navigator Expands US Ethylene Terminal
Gas shipping company Navigator Holdings is expanding the capacity of its ethylene export terminal near Houston, Texas, USA, that it operates as a 50:50 joint venture with Enterprise Products Partners.
10.03.2023 • News
German Chemical Industry Mood Brightens
The mood of the German chemical industry brightened at the beginning of 2023 on the back of a sharp downslide in the last quarter of 2022, when production slumped by 14%, producers operated plants at around three-quarters of capacity, demand sank and sales declined both in domestic and foreign markets.
10.03.2023 • News
German Merck and Intel in AI Research Project
German chemicals, pharmaceuticals and life sciences group Merck and US semiconductors giant Intel have signed a letter of intent to fund a European academic research program that will leverage artificial intelligence (AI) and machine learning technologies to drive innovation.
10.03.2023 • News
Solenis Takes Diversey for $4.6 Billion
US specialty chemicals company Solenis is to take over disinfectant producer Diversey Holdings in an all-cash transaction valued at about $4.6 billion, including debt.
09.03.2023 • News
BASF Expands Aroma Ingredients in China, Germany
BASF is expanding its global capacity for aroma ingredients citral, menthol and lnaloon at existing locations in China and Germany. The biggest investment will involve construction of a new citral plant at its growing integrated site in Zhanjiang, China. New plants for menthol and linalool will to be built at Ludwigshafen.
09.03.2023 • News
Perstorp Selects Johnson Matthey for Methanol Project
Swedish chemical company Perstorp has selected Johnson Matthey to provide the license and engineering for its Product Air methanol plant at Stenungsund.
09.03.2023 • News
SABIC to Build Catalyst Plants in Saudi Arabia
SABIC has announced it is planning to build three new plants in Saudi Arabia to produce catalysts used in the manufacture of chemicals and polymers.
08.03.2023 • News
Bachem Inks $531 Million Peptides Manufacturing Deal
Bachem, a Swiss specialist developer and manufacturer of peptides and oligonucleotides, has signed another order worth more than 500 million Swiss francs – or $531 million – to supply large volumes of peptides following a joint development project. The identity of the customer has not been disclosed.
08.03.2023 • News
Safic-Alcan Acquires Plastics Distributor 4PLAS
Independent French specialty chemicals distributor Safic-Alcan has acquired UK engineering plastics distributor 4PLAS for an undisclosed sum.
08.03.2023 • News
Cabot to Set up European Battery Technology Center
US specialty chemicals producer Cabot has chosen Münster, Germany, as the site of a planned new technology center to guide its efforts toward meeting the growing demand for electric vehicle (EV) lithium-ion batteries in Europe, the Middle East and Africa (EMEA).
07.03.2023 • News
Solvay Agrees RusVinyl Sale
Solvay has now finalized terms to sell its half share in Russian PVC producer RusVinyl to its joint venture partner Sibur.
07.03.2023 • News
Moderna Chooses Oxfordshire Site for UK Tech Center
US vaccine maker Moderna has chosen the Harwell Science Campus in Oxfordshire, England, as the location for its planned UK Innovation and Technology Center which is expected to be in operation by 2025.
07.03.2023 • News
Novo Nordisk Restructures R&D Services in the US
Danish pharma Novo Nordisk is expanding its R&D capabilities in Boston, Massachusetts, US, which will lead to the closure of a facility in Indianapolis and a restructuring of its Seattle operations.
06.03.2023 • News
ADNOC Raises $2.5 Billion in Gas IPO
Abu Dhabi National Oil Co (ADNOC) has netted $2.5 billion from the initial public offering of its subsidiary ADNOC Gas. The biggest-ever issue in Abu Dhabi, topping the $2 billion Borouge listing in mid-2022, was oversubscribed more than 50 times as investors placed offers worth $124 billion for a 5% stake in the United Arab Emirates-based firm.
06.03.2023 • News
BP Invests in Spanish Green Hydrogen/Biofuels Capacity
BP is investing up to €2 billion in a green hydrogen plant at its Castellon refinery in Spain, replacing the site’s existing fossil-fuel based facility and expanding production of biofuels threefold. The project is the basis of a public-private initiative named HyVal and led by BP to decarbonize the Valencia region, including the Castellon refinery.
06.03.2023 • News
Clean Cells Opens New €22 Million Facility
Clean Cells, part of France’s Clean Biologics group, which provides biopharmaceutical product quality control services and manufactures starting materials, has begun analytical activities at its new €22 million facility in Montaigu-Vendée, near Nantes.
03.03.2023 • News
Aenova Appoints Hanno Scheffczik as Managing Director of its Marburg Site
Hanno Scheffczik has been appointed as the new Managing Director of Temmler Pharma, a member of the Aenova Group. Effective Mar. 1, 2023, he succeeds Alfred Veit, who is retiring.
03.03.2023 • News
US Uncovers Covid-related Bogus API-making Deals
Under US president Joe Biden, the Department of Justice has been moving energetically of late to uncover and prosecute offenses that might otherwise have been swept under heavy rugs, including Covid-related API manufacturing contracts won under unclear circumstances.
03.03.2023 • News
IMCD UK Buys Orange Chemicals
In its second deal of 2023 so far, IMCD has acquired Orange Chemicals, a distributor covering the coatings & construction, advanced materials and other industrial markets in the UK and Ireland.
